BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients

Annals of Oncology

Volumn 15, Issue 9, 2004, Pages 1373-1376

  Rogozinska Szczepka J ^a   Utracka Hutka, B ^a   Grzybowska, E ^a   Maka, B ^a   Nowicka, E ^a   Smok Ragankiewicz, A ^a   Zientek, H ^a   Steffen, J ^b   Wojciechowska Lacka A ^c  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Wielkopolska Cancer Center   (Poland)

Author keywords

Bilateral breast cancer; BRCA1 2; Prognostic factors

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER INCIDENCE; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENETIC SIMILARITY; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STOMACH CANCER; UTERUS CANCER;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; PROGNOSIS; RISK FACTORS;

EID: 4644221274     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh352     Document Type: Article

References (34)

1. Leis HP. Managing the remaining breast. Cancer 1980; 46: 1026-1030.
2. Adami HO, Bergstrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cancer 1985; 55: 643-647.
3. Engin K. Prognostic factors I bilateral breast cancer. Neoplasma 1994; 41: 353-357.
4. Heron DE, Komarnicky LT, Hyslop T. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88: 2739-2749.
5. Nicoletto MO, Donach M, de Nicolo A et al. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counseling. Cancer Treat Rev 2001; 27: 295-304.
6. Easton D, Ward S, Ford D et al. The genetic epidemiology of BRCA 1. Lancet 1994; 344: 761.
7. Shattuck-Eidens D, Oliphant A, McClure M et al. BRCA 1 sequence analysis in women at high risk for susceptibility mutations. JAMA 1997; 278: 1242-1250.
8. Ford D, Easton DF, Bishop D et al. Risk of cancer in BRCA 1 mutation carriers. Lancet 1994; 343: 692-695.
9. Antoniou A, Pharoah PDP, Narod S et al. Average risks of breast and ovarian cancer associated with BRCA 1 or BRCA 2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-1130.
10. Green MH. Genetics of breast cancer. Mayo Clin Proc 1997; 72: 54-65.
11. Chan PCR, Wong BYL, Ozcelik H et al. Simple and rapid detection of BRCA 1 and BRCA 2 mutations by multiplex mutagenically separated PCR. Clin Chem 1999; 45: 1285-1287.
12. Grzybowska E, Siemińska M, Zientek M et al. Germline mutations in the BRCA 1 gene predisposing to breast and ovarian cancer in Upper Silesia population. Acta Biochemica Polonica 2002; 49: 351-356.
13. Adami HO, Hansen J, Jung B et al. Bilateral carcinoma of the breast: epidemiology and histopathology. Acta Radiol Oncol 1981; 20: 305-309.
14. Gogas J, Markopoulos CH, Skandalakis P et al. Bilateral Breast Cancer. Am Surg 1993; 59: 733-735.
15. Malone KE, Daling JR, Thompson JD et al. BRCA 1 mutations and breast cancer in general population; analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 1998; 279: 922-929.
16. Broet PH, de la Rochefordiere A, Scholl SM et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 1995; 13: 1578-1583.
17. Bailey MJ, Royce C, Sloane JP et al. Bilateral carcinoma of the breast. Br J Surg 1980; 67: 514-516.
18. Adami H, Hansen J, Jung B et al. Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer 1981; 48: 1688-1695.
19. Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with histologic, clinical and therapeutic factors. Cancer 1988; 62: 412-424.
20. Gump FE. Lobular carcinoma in situ: pathology and treatment. Surg Clin N Am 1990; 70: 873-883.
21. Cook LS, White E, Scheartz SM et al. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington United States). Cancer Causes Control 1996; 7: 382-390.
22. Newman LA, Sabin AA, Bondy M et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 2001; 91: 1845-1853.
23. Johannsson OT, Idvall I, Anderson C et al. Tumor biological features of BRCA 1 induced breast and ovarian cancer. Eur J Cancer 1997; 33: 362-371.
24. Armes JE, Egan AJM, Southey MC et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with or without BRCA 1 or BRCA 2 germline mutations: a population based study. Cancer 1998; 83: 2335-2345.
25. Eisenger F, Jacquemier J, Charpin C et al. Mutations at BRCA 1: medullary breast carcinoma revisited. Cancer Res 1998; 58: 1588-1592.
26. Lakhani SR, Jaquemier J, Sloane JP et al. Multifactorial analysis of differences between sporadic breast cancer and cancers involving BRCA 1 and BRCA 2 mutations. J Natl Cancer Inst 1998; 90: 1138-1145.
27. Verhoog LC, Brekelmans CTM, Seynaeve C et al. Contralateral breast cancer risk is influenced by the age at onset in BRCA-1 associated breast cancer. Br J Cancer 2000; 83: 384-386.
28. Ford D, Easton D, Stratton M et al. Genetic heterogenicity and penetrance analysis of the BRCA 1 and BRCA 2 genes in breast cancer families. Am J Hum Genet 1998; 62: 676-689.
29. Verhoog LC, Brekelmans CTM, Seynaeve C et al. Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA 1. Lancet 1998; 351: 316-321.
30. Gershoni-Baruch R, Dagan E, Fried G et al. BRCA 1 and BRCA 2 founder mutations in patients with bilateral breast cancer. Eur J Hum Genet 1999; 7: 883-886.
31. Bergharsson JT, Ejlertsen B, Olsen JH et al. BRCA 1 and BRCA 2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. Breast Cancer Res Treat 2000; 64: 241-251.
32. Turner BC, Harrold E, Matloff E et al. BRCA 1/BRCA 2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA 1/BRCA 2 mutations. J Clin Oncol 1999; 17: 3017-3024.
33. Steinmann D, Bremer M, Rades D et al. Mutations of the BRCA 1 and BRCA 2 genes in patients with bilateral breast cancer. Br J Cancer 2001; 85: 850-858.
34. Dawson LA, Chow E, Goss PE. Evolving perspectives in contralateral breast cancer. Eur J Cancer 1998; 34: 2000-2009.